What does Oncomfort do?

Oncomfort is an IT company in Wavre. Public Limited, started on 11 April 2017, 1 establishment.

What is the address of Oncomfort?

The registered office of Oncomfort is located at Avenue Einstein 16 box 12, 1300 Wavre.

Is Oncomfort still active?

No. The CBE lists Oncomfort with legal situation “Opening faillissement”. The date of the court ruling is published in the Belgian Official Gazette; the register does not carry it.

Is Oncomfort registered on Peppol?

No, Oncomfort is currently not registered on the Peppol network.

What is the enterprise number of Oncomfort?

The enterprise number of Oncomfort is BE0674419521.

When was Oncomfort founded?

Oncomfort was founded on 11 April 2017.

Who are the directors of Oncomfort?

According to the 2021 annual accounts, the directors of Oncomfort are: CREDIT MUTUEL INNOVATION, Jérôme Majoie, Diane Jooris, TRANSFORM MEDICAL GMBH, ARIOM, DEBIOPHARM INNOVATION FUND.

Is Oncomfort a reliable company?

Databakkes does not pass judgement; this is what the sources say: Opening faillissement according to the CBE, started on 11 April 2017; 1 annual account filed (fiscal year 2021); 6 directors known from the annual account.

How much profit did Oncomfort make in 2021?

Oncomfort recorded a loss after taxes of € 1,601,026 in financial year 2021.

What is the revenue of Oncomfort?

As a small company, Oncomfort is not required to publish revenue in its annual accounts. In financial year 2021, its added value was € -490,819.

Oncomfort (Public Limited) - Wavre - BE0674419521

Dossier Oncomfort, printed on 16 September 2026 from databakkes.be/en/0674419521/oncomfort. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Legal situation KBO

Opening faillissement according to the CBE.

Financials

Financial year 2021

Oncomfort from Wavre, company number BE0674419521, closed financial year 2021 with a result of € -1.6 million after tax. For that financial year Oncomfort recorded a gross margin of € -490,819 and equity of € 4.1 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 5, 2022.

What it is worth Healthy

€ 4.1 million

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -1.6 million

Profit after tax over the fiscal year.

Cash in the bank

€ 2.9 million

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -3.9 million.

People and assets in 2021

Wage cost

€ 788,980

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 385

Book value of vehicles, furniture and equipment.

Debts at end 2021

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 204,913

€ 23,438 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 234,962

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 214,695

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

What happened to Oncomfort?

What happened at Oncomfort in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oncomfort is active according to the CBE. Legal situation: Opening faillissement.

2027 TRANSFORM MEDICAL GMBH stepped down as director. NBB
2026 CREDIT MUTUEL INNOVATION stepped down as director. NBB
2026 DEBIOPHARM INNOVATION FUND stepped down as director. NBB
2024 Jérôme Majoie stepped down as director. NBB
Sep 5, 2022 New annual accounts for financial year 2021: loss of € 1.6 million. filed late Source: NBB ↗
2022 Diane Jooris stepped down as director. NBB
2022 ARIOM stepped down as director. NBB
2021 TRANSFORM MEDICAL GMBH became a director. NBB

In short

Paid € 978 in corporate taxes since 2021.

Original PDFs at the National Bank ↗

A new publication or filing at Oncomfort? We notify you, reason included.

Follow Oncomfort

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Directors

According to the 2021 annual accounts

CREDIT MUTUEL INNOVATION

Director · represented by Delphine CARDI

since 2020 · until 2026

Jérôme Majoie

Director

Also active at: ATB THERAPEUTICS, Inteliphage, The Oncidium Foundation

since 2018 · until 2024

Diane Jooris

Director

since 2017 · until 2022

TRANSFORM MEDICAL GMBH

Director · represented by Kar SCHWEITZER

since 2021 · until 2027

ARIOM

Managing director · represented by Mario HUYGHE

since 2018 · until 2022

DEBIOPHARM INNOVATION FUND

Director · represented by Tanja Dowe

since 2020 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Einstein 16 box 12

1300 Wavre

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

INTERNATIONAL SOURCING GROUP

€ -7,758 gross margin · 2025

MOVING PEOPLE

€ 886,386 gross margin · 2025

CECAMA

€ 51,349 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0674.419.521

VAT number

BE 0674.419.521

Registered office

Avenue Einstein 16 bus 12, 1300 Wavre

Names & denominations

Oncomfort

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Opening faillissement

Start date

11 April 2017

Peppol

Not registered

Activities · NACE

Ontwerpen van computerprogramma’s

Ontwerpen en programmeren van computerprogramma's

Overige diensten op het gebied van informatietechnologie en computer

Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten

Computerconsultancy-activiteiten

View on CBE Public ↗ Annual accounts (NBB) ↗